15 Einträge gefunden

1. Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma

   1. Scheiner, Bernhard
   2. Roessler, Daniel
   3. Phen, Samuel
   4. Lim, Mir
   5. Pomej, Katharina
   6. Pressiani, Tiziana
   7. Cammarota, Antonella

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

   1. Vithayathil, Mathew
   2. D'Alessio, Antonio
   3. Fulgenzi, Claudia Angela Maria
   4. Nishida, Naoshi
   5. Schönlein, Martin
   6. von Felden, Johann
   7. Schulze, Kornelius

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
3. Circulating tumor cells as a preoperative risk marker for occult metastases in patients with resectable cholangiocarcinoma

   1. Fründt, Thorben
   2. von Felden, Johann
   3. Krause, Jenny
   4. Heumann, Asmus
   5. Li, Jun
   6. Riethdorf, Sabine
   7. Pantel, Klaus

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score

   1. Scheiner, Bernhard
   2. Pomej, Katharina
   3. Kirstein, Martha M
   4. Hucke, Florian
   5. Finkelmeier, Fabian
   6. Waidmann, Oliver
   7. Himmelsbach, Vera

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: a real-world study

   1. D'Alessio, Antonio
   2. Fulgenzi, Claudia Angela Maria
   3. Nishida, Naoshi
   4. Schönlein, Martin
   5. von Felden, Johann
   6. Schulze, Kornelius
   7. Wege, Henning

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
6. Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

   1. Vithayathil, Mathew
   2. D'Alessio, Antonio
   3. Fulgenzi, Claudia Angela Maria
   4. Nishida, Naoshi
   5. Schönlein, Martin
   6. von Felden, Johann
   7. Schulze, Kornelius

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
7. Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients

   1. Fründt, Thorben
   2. Krause, Linda
   3. Hussey, Elaine
   4. Steinbach, Bettina
   5. Köhler, Daniel
   6. von Felden, Johann
   7. Schulze, Kornelius

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
8. Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas

   1. Wege, Henning
   2. Schulze, Kornelius
   3. von Felden, Johann
   4. Calderaro, Julien
   5. Reig, Maria

   2021 - Forschungsinformationssystem des UKE
9. Sequential Systemic Treatment in Advanced Hepatocellular Carcinoma Is Able to Prolong Median Survival to More than 3 Years in a Selected Real-World Cohort

   1. von Felden, Johann
   2. Karkmann, Kathrin
   3. Ittrich, Harald
   4. Gil-Ibanez, Ines
   5. Fründt, Thorben
   6. Krause, Jenny
   7. Lohse, Ansgar W

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
10. Elevated Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predicts Poor Outcome in Hepatocellular Carcinoma

    1. von Felden, Johann
    2. Wege, Henning
    3. Schulze, Kornelius

    2020 - Forschungsinformationssystem des UKE
11. Liquid biopsy in the clinical management of hepatocellular carcinoma

    1. von Felden, Johann
    2. Garcia-Lezana, Teresa
    3. Schulze, Kornelius
    4. Losic, Bojan
    5. Villanueva, Augusto

    2020 - Forschungsinformationssystem des UKE
12. Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort

    1. Scheiner, Bernhard
    2. Kirstein, Martha M
    3. Hucke, Florian
    4. Finkelmeier, Fabian
    5. Schulze, Kornelius
    6. von Felden, Johann
    7. Koch, Sandra

    2019 - Forschungsinformationssystem des UKE
13. High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection

    1. von Felden, Johann
    2. Heim, Denise
    3. Schulze, Kornelius
    4. Krech, Till
    5. Ewald, Florian
    6. Nashan, Björn
    7. Lohse, Ansgar W

    2017 - Forschungsinformationssystem des UKE - frei zugänglich
14. Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection

    1. von Felden, Johann
    2. Schulze, Kornelius
    3. Krech, Till
    4. Ewald, Florian
    5. Nashan, Björn
    6. Pantel, Klaus
    7. Lohse, Ansgar W

    2017 - Forschungsinformationssystem des UKE
15. First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma-An Update on Patient Selection and Response Evaluation

    1. von Felden, Johann
    2. Schulze, Kornelius
    3. Gil-Ibanez, Ines
    4. Werner, Tobias
    5. Wege, Henning

    2016 - Forschungsinformationssystem des UKE - frei zugänglich